Skip to content

Finished goods at other companies

TFX
TeleflexTFX
$237.86M-28.5%
LivaNova logo
LivaNovaLIVN
$75.09M+12.2%
Haemonetics logo
HaemoneticsHAE
$189.37M-16.0%
ICU Medical logo
ICU MedicalICUI
$289.36M+9.9%
iRhythm Holdings, Inc.
 logo
iRhythm Holdings, Inc. IRTC
$11.73M+27.9%
Medtronic logo
MedtronicMDT

Other financials

Income statement

See full
Revenue$439.6M+0.5%
Gross profit$109.6M-8.9%
Operating income$31.9M-35.7%
Net income$16.5M+173%
EPS (diluted)$0.48+173%

Balance sheet

See full
Cash & equivalents$8.1M-74.4%
Total debt$1.4B+2.0%
Total equity$1.7B+5.6%
Total assets$3.4B+3.5%

Cash flow

See full
Operating cash flow$24.7M-21.0%
CapEx$24.0M-5.0%
Free cash flow$737.0K-87.8%

Valuation

See full
Market cap$3.04B-27.0%
Enterprise value$4.41B-19.6%
P/E21.4×-32.8×
P/S1.6×-0.7×

Profitability

See full
Gross margin26.4%-0.6pp
Operating margin11%-1.6pp
Net margin7.6%+3.2pp
FCF margin5.4%-1.0pp

Returns & leverage

See full
Return on equity8.6%+3.7pp
Debt / equity0.8×0.0×
Current ratio3.8×+0.4×

Where this comes from

Reported directly by Integer Holdings in its filing.

Tagged under the XBRL concept us-gaap:InventoryFinishedGoodsNetOfReserves.

The official record: Integer Holdings’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Integer Holdings's finished goods.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Integer Holdings's finished goods?
Integer Holdings (ITGR) reported finished goods of $23.36M in Q1 2026.
How has Integer Holdings's finished goods changed year-over-year?
Integer Holdings's finished goods increased by 44.2% year-over-year, from $16.2M to $23.36M.
What is the long-term trend for Integer Holdings's finished goods?
Over 5 years (2020 to 2025), Integer Holdings's finished goods has grown at a -2.2% compound annual growth rate (CAGR), from $18.04M to $16.14M.
What does finished goods mean?
Completed products ready for sale, valued at the lower of cost or net realizable value.